BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

NCT01034631 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

154

Enrollment

OTHER

Sponsor class

Conditions

Renal Cell Carcinoma

Interventions

DRUG: Everolimus
DRUG: BNC105P

Sponsor

Hoosier Cancer Research Network

Collaborators

[object Object]